Blossom Health has raised $20 million across Seed and Series A rounds to scale its AI-powered operating system for psychiatry, aiming to address the growing shortage of mental health providers in the United States. The Series A was led by Headline, with participation from returning investors Village Global and TA Ventures, as well as new investors including Operator Partners and Correlation Ventures. The round also attracted a broad group of healthcare and technology founders as angel investors.

The company is building an integrated platform that connects psychiatrists, patients, payors, pharmacies, and referral networks into a single AI-coordinated system. The goal is to expand access to psychiatric care by enabling clinicians to treat more patients efficiently while reducing administrative burden. Founder and CEO John Zhao said the platform is designed to “supercharge” psychiatrists, making mental healthcare more affordable and accessible at scale.

Blossom’s platform combines clinical decision support with operational automation. AI copilots assist clinicians with diagnosis, treatment planning, and medication selection, while administrative workflows—such as scheduling, billing, documentation, and care coordination—are automated. The company says this approach allows providers to focus more on patient care while improving outcomes and reducing progression to higher levels of care.

The new funding will support geographic expansion, onboarding of more psychiatrists and nurse practitioners, partnerships with national and regional health insurers, and continued development of AI capabilities. Blossom currently operates across multiple U.S. states, works with major insurers including UnitedHealthcare, Aetna, Cigna, and Blue Cross Blue Shield, and enables patients to access care quickly—often within 48 hours or less.

Click here to read the original news story.